SecBot SecBot
SECBOTREPLAY Home › Report › LGND

LGND · Director John W

LIGAND PHARMACEUTICALS INC · 144 filed Nov 12, 2026 at 16:04 ET

At the news

NEUTRALIMPACT 2/10

144 filed Nov 12, 2026 at 16:04 ET

Director John W. Kozarich filed a Form 144 notice of intent to sell 500 shares of Ligand Pharmaceuticals common stock, with an estimated aggregate market value of approximately $162,500. The shares were acquired through stock awards in 2022 and 2025. This is a small, routine sale by a director and does not signal a material change in the company's outlook.

  • Reporting person: John W. Kozarich, Director
  • Securities to be sold: 500 shares of Common Stock
  • Estimated aggregate market value: $162,500
  • Shares acquired via stock awards on 02/28/2022 and 06/06/2025

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access